Epidemiology of Adult Soft-Tissue Sarcomas in Germany

Table 5

Five-year survival and median survival, overall and by sex, age, and histologic category (for the five most common) among cases diagnosed from 2003 to 2012 in nine German states.

Group	Number at risk	Died		Five-year survival probability (95% CI)^a	Median survival time in years (95% CI)^a
		n	(%)
Overall	24,753	10,382	(41)	0.52 (0.52–0.53)	5.83 (5.50–6.08)
Sex
Male	12,367	5,220	(41)	0.52 (0.51–0.53)	5.67 (5.33–6.00)
Female	12,386	5,162	(41)	0.53 (0.52–0.54)	6.00 (5.59–6.58)
Age at diagnosis (years)
18–44	3,810	933	(26)	0.71 (0.70–0.73)	NE
45–54	3,615	1,100	(31)	0.65 (0.63–0.67)	NE
55–64	4,357	1,646	(36)	0.58 (0.56–0.59)	8.33 (7.67–NE)
65–74	6,368	2,837	(46)	0.50 (0.48–0.51)	4.92 (4.58–5.33)
75+	6,603	3,866	(56)	0.33 (0.31–0.34)	2.25 (2.08–2.34)
Histologic category
Fibroblastic/myofibroblastic	2,986	701	(26)	0.73 (0.71–0.75)	NE
Leiomyosarcoma	4,814	2,106	(46)	0.50 (0.48–0.52)	5.00 (4.59–5.58)
Liposarcoma	3,872	1,050	(26)	0.69 (0.67–0.71)	NE
Sarcoma, NOS	3,583	1,896	(51)	0.41 (0.39–0.43)	2.42 (2.17–2.83)
Fibrohistiocytic	2,349	1,086	(46)	0.49 (0.47–0.51)	4.92 (4.33–5.41)

CI: confidence interval; n: the number of cases who died; NE: not estimable; NOS: not otherwise specified; ^acalculated using the Kaplan–Meier method. 24 cases with missing year of death were excluded from this analysis (representing less than 0.3% of the cases who died); data in this table are limited to the nine federal states with at least 90% completeness.